Fortress Biotech (FBIO) Cut to Sell at ValuEngine


A number of other research analysts also recently issued reports on FBIO. HC Wainwright set a $11.00 price objective on shares of Fortress Biotech and gave the company a "buy" rating in a research report on Thursday, August 10th.



from Biotech News